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Abstract 
Pregnant women may be exposed to 
nonionizing, ionizing radiation and contrast 
media via diagnostic or therapeutic procedures 
and workplace exposure. When computed 
tomography or magnetic resonance imaging is 
performed on a pregnant woman, the effects of 
exposure to radiation, high magnetic fields and 
contrast media, which can be risky for a fetus, 
should be considered. Nonionizing radiation that 
is not significantly risky for a fetus includes 
microwave, ultrasound, radio frequency and 
electromagnetic waves, while ionizing radiation 
that can be teratogenic, carcinogenic or 
mutagenic includes particles and 
electromagnetic radiation. The effects of 
radiation are associated with the level of 
exposure and stage of fetal development. 
Organogenesis (two to seven weeks after 
conception) and the early fetal period (eight to 
fifteen weeks after conception) are the most 
sensitive stages for a fetus. Noncancerous 
health effects have not been determined at any 
stage of gestation with less than 50 mGy (5 rad) 
exposure dose of ionizing radiation. Higher 
exposure levels may lead to spontaneous 
abortion, growth restriction, and mental 
retardation. The risk of cancer is increased 
regardless of the dose. Although the use of 
iodinated contrast media is generally thought to 
be safe during pregnancy, the risk of fetal 
hypothyroidism should be considered and it 
should be used only when necessary. The use 
of gadolinium-based contrast media during 
pregnancy is controversial because of the lack 
of clinical data. The purpose of this article is to 
review the existing literature regarding the 
prenatal radiation exposure and to discuss fetal 
risk of radiation. 
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Introduction 
All persons are regularly exposed to 
radiation such as environmental 
radiation and radiation from industrial 
and medical sources.  In the past 10 
years, radiological examinations 
performed in pregnant women have 
increased by 107% and the greatest 
increase is seen in use of contrast 
enhanced computed tomography (CT).1 
Although ultrasonography (US) is the 
first preferred radiological examination 
in pregnant women, CT and magnetic 
resonance imaging (MRI) are 
occasionally required in some cases, 
and these examinations often require 
the intravenous injection of contrast 
media. Physicians should know about 
the potential effects of radiation and 
contrast media so as to provide 
appropriate management of pregnant 
women.2 The aim of this study is to 
review the literature regarding prenatal 
radiation exposure and to discuss the 
types, effects and fetal risks of radiation. 
Forms of radiation 
Radiation, emitted as particles or waves 
is a kind of fast-moving energy which is 
classified as nonionizing and ionizing 
radiation. In nonionizing low-frequency 
radiation, energy is dispersed through 
heat and increased molecular 
movement; this includes visible light, 
ultraviolet rays, microwave, ultrasound, 
radio frequency and some 
electromagnetic waves. Ionizing 
radiation includes particles (alpha and 
beta particles) and electro-magnetic 
radiation (gamma rays and x-rays) and it 
can alter the normal structure of a living 
cell.3 The average annual exposure of 
radiation from cosmic rays, radioactive 
substances in the environment and 
naturally occurring radiation in the 
human body is 1 mGy (0.1 rad).4 
Common medical applications of 
nonionizing and ionizing radiation are 
presented in Table 1.  
Table 1. Common medical applications of non-ionizing and ionizing radiation 
 
 
Abbreviations: CT, computed tomography; DSA, digital substraction angiography; MRI, magnetic 
resonance imaging; PET, positron emission tomography; RT, radiation therapy; RF, radiofrequency; 
SPECT, single-photon emission computed tomography; US, ultrasonography. 
Type of radiation Medical application 
Ionizing radiation  
    Gamma Rays PET 
 RT 
 SPECT 
     X-rays      CT 
 DSA 
 Duel-energy x-ray absorptiometry 
 Fluoroscopy 
 Mammography 
 RT 
 Radiography 
Non-ionizing radiation  
      Electromagnetic and RF waves MRI 
      Ultrasound US 
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Non-ionizing radiation 
Nonionizing radiation interacts with the 
tissue through the formation of heat. 
The effect of in utero exposure to 
nonionizing radiation has been 
evaluated, and no major risks have 
been detected.5  
The most common type of diagnostic 
nonionizing radiation performed in 
pregnant women is ultrasound. Previous 
studies reported that there is no 
relationship between prenatal US and 
adverse fetal effects such as childhood 
malignancies including mental 
retardation.6  However, US has thermal 
tissue effects and it is advised to be 
performed using the lowest possible 
exposure setting under the ALARA (as 
low as reasonably achievable) 
principle.7  
MRI is another type of nonionizing 
radiation used in medicine.2 The 
advantages of MRI are multiplanar 
capability and excellent evaluation of 
soft-tissue.8 The risks of MRI in 
pregnant women have been evaluated 
with computer simulations and animal 
models. The risk to the fetus on 1.5-
Tesla (The unit for the MRI systems that 
shows the strength of the magnetic field 
they produce. 1 Tesla=10,000 gauss, 
earth’s magnetic field is 0.5 gauss) MRI 
appear to be nonsignificant.9 However, 
the possible risks of MRI with higher 
field strength have not been extensively 
evaluated. In 2007, the American 
College of Radiology (ACR) guidelines 
for MRI recommended that MRI should 
be used when the risk-benefit ratio 
warrants the study. The heat of the 
magnetic field may cause a possible risk 
to the fetus, especially in the first 
trimester.10 Another potential risk of MRI 
is that of acoustic injury. However, 
previous studies reported that this 
possible risk seems less likely, since 
sound is attenuated through amniotic 
fluid and it generally affects the fetus at 
a level of less than 30 dB.10 In 1991, the 
Safety Committee of the Society of MRI 
stated that MRI may be performed in 
pregnant women when US is 
inadequate or insufficient. They also 
stated that pregnant women should be 
informed about the fact that MRI during 
pregnancy did not have any deleterious 
effects to date.11,12  
Ionizing Radiation 
Ionizing radiation acts directly with the 
biochemical structures in tissue 
(including proteins, DNA, and other 
molecules) or indirectly by leading to the 
formation of free radicals. The effects of 
exposure may be classified under 2 
types; deterministic and stochastic 
effects.13  
Deterministic effects 
Deterministic effects are caused by high 
exposure doses of radiation. These 
effects are predictable and involve 
multicellular injury, including 
chromosome aberrations.14 The 
threshold dose for the evaluation of the 
pregnancy has been estimated to be 
150 mGy (15 rad).15 At this dose, it is 
recommended that the pregnancy 
should be evaluated for the need of 
intervention, such as termination of 
pregnancy. Theoretical risks at this dose 
include a less than 3% chance of cancer 
development, a 6% chance of mental 
retardation, loss of intelligence quotient 
(IQ) points by 30 points per 100 mGy, 
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and a 15% chance of microcephaly.13,14  
However, the risks depend on the timing 
and dose of the exposure in early 
gestation (Table 2).16  Although there is 
theoretical risk with any exposure to 
ionizing radiation, the dose exposed to 
the fetus from a single diagnostic 
examination is generally much less than 
50 mGy (5 rad) which can be regarded 
as threshold value for noncancerous 
health effects of ionizing radiation. Table 
3 presents the average values for fetal 
radiation doses of diagnostic imaging 
examinations.2,8,17,18   
Table 2. Potential effects to the fetus of various radiation exposure doses in 
various gestational ages16 
Gestational age (week)  Potential effects of radiation exposure doses 
 
   <50 mGy 50-100 mGy >100 mGy 
 0-2  None  None  None 
 3-4  None  Probably none Possible spontaneous abortion 
 5-10  None  Uncertain Possible malformations 
 11-17  None  Uncertain Possible deficits in IQ or mental retardation 
 18-27  None  None  IQ deficits not detectable at diagnostic doses 
 >27  None  None  None applicable to diagnostic medicine 
 
Abbreviations: IQ, intelligence quotient. 
 
 
Stochastic effects 
Stochastic effects are the result of 
cellular damage, presumably at the DNA 
level, that leads to cancer or other germ 
cell mutations. Stochastic effects have 
no threshold value and are thought to 
occur with any exposure dose of 
ionizing radiation. The severity of 
stochastic effects is independent of the 
radiation dose. The radiation dose 
estimated for stochastic effects was 
established at 50 mGy (5 rad).10 It is 
considered that this level provides a 
margin of safety from higher 
exposures.14,19  It is reported that the 
risk of childhood cancer doubles with 
exposures over 50 mGy.20  However, 
this value is not regarded as current in 
these days, since no radiation effects 
have been clearly reported at this level. 
In 2008, ACR provided guidelines for 
imaging in pregnant women and 
estimated fetal risk of various radiation 
exposure doses in various gestational 
ages [Table 2].16 These values are 
provided from animal studies, 
epidemiological studies of survivors in 
Japan at the time of atomic bombings 
and studies of groups exposed to 
radiation for medical reasons such as 
radiation therapy for uterus carcinoma.9  
Contrast media 
Studies of iodinated low osmolality 
contrast media (LOCM) in diagnostic X-
ray and CT, and gadolinium-based 
contrast agents (GBCAs) in MRI in 
pregnancy have been limited, and their 
effects on the human embryo or fetus 
are imperfectly understood. The 
assumption is that all iodinated and 
gadolinium-based contrast media 
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behave similarly crossing the blood-
placenta barrier into the fetus.21 The 
agents will be excreted through the 
urine into the amniotic fluid which will 
then be swallowed by the fetus.23 It is 
then possible that a small amount will be 
absorbed from the gut of the fetus with 
the additional swallowed gadolinium-
based contrast agents eliminated back 
into the amniotic fluid. There are no data 
available to assess the rate of clearance 
of contrast media from the amniotic 
fluid.21  
Table 3. Fetal radiation doses of common imaging examinations2,8,17,18 
 
Type of examination Fetal dose* (mGy) 
Very low dose examinations (<0.1 mGy)  
     Cervical spine radiography (2 views) <0.001 
     Radiography of any extremity <0.001 
     Mammography (2 views) 0.001-0.01 
     Chest radiography (2 views) 0.0005-0.01 
Low to moderate dose examinations (0.1-10 
mGy) 
 
Radiography  
          Abdominal radiography 0.1-3.0 
          Lumber spine radiography 1.0-10 
          IVP 5-10 
          Double contrast barium enema 1.0-2.0 
CT  
          Head or neck CT 1.0-10 
          Chest CT or CT pulmonary angiography 0.01-0.66 
          Limited CT pelvimetry <1 
Nuclear Medicine  
          Low dose perfusion scintigraphy 0.1-0.5 
          Technetium-99m bone scintigraphy 4-5 
          Pulmonary digital substraction angiography 0.5 
Higher dose examinations (10-50 mGy)  
     Abdominal CT 1.3-35 
     Pelvic CT 10-50 
     18 F PET/CT whole-body scintigraphy 10-50 
 
Abbreviations: CT, computed tomography; 18 F PET/CT, 2-[fluorine-18]fluoro-2-deoxy-D-glucose 
positron emission tomography/computed tomography; IVP, intravenous pyelography.  
Annual average background radiation=1.1-2.5 mGy.  
 
*Fetal exposure varies with gestational age, maternal body habitus, and exact acquisition parameters. 
 
 
Iodinated Low Osmolality Contrast 
Media (LOCM) 
In-vivo tests in animals have shown no 
evidence of either mutagenic or 
teratogenic effects with LOCM.8,9  No 
adequate and well-controlled 
teratogenic studies of the effects of 
these media in pregnant women have 
been performed. The effects of LOCMs 
on fetal thyroid functions are crucial 
Proceedings in Obstetrics and Gynecology, 2015;5(1):2 
Prenatal radiation exposure 6 
 
because the fetal thyroid plays an 
important role in the development of the 
central nervous system.9 There have 
been rare reports of hypothyroidism 
developing in the newborn infant after 
the administration of iodinated contrast 
medium during pregnancy; however, 
this occurred only following amino 
fetography using fat-soluble iodinated 
contrast medium which was performed 
in the past to detect congenital 
malformations. Intravenous (IV) 
administration of iodinated contrast 
media doesn’t affect short-term neonatal 
thyroid stimulating hormone (TSH), 
likely because the overall amount of 
excess iodide in the fetal circulation is 
very small; however, the long term 
effects are unknown.21 To date, there 
has been no documented case of 
neonatal hypothyroidism from the 
maternal intravascular injection of water-
soluble iodinated contrast agents.23 
There have been no other adverse 
effects that have been reported in the 
fetus or neonate following administration 
of LOCM; however, information on this 
issue is inadequate.21 
Gadolinium-based contrast agents 
(GBCAs) 
To date, there have been no known 
adverse effects to the human fetus 
reported when clinically recommended 
dosages of GBCAs have been given to 
pregnant women. A single cohort study 
of 26 women exposed to gadolinium 
chelates during the first trimester pf 
pregnancy showed no evidence of 
teratogenesis or mutagenesis in their 
progeny.24 However, no adequate and 
well-controlled teratogenic studies of the 
effects of these media in pregnant 
women have been performed. GBCAs 
nephrogenic systemic fibrosis (NSF) is a 
potential risk, but there are no known 
cases of NSF linked to the use of 
GBCAs in pregnant patients to date. 
Gadolinium chelates may accumulate in 
the amniotic fluid; therefore, there is the 
potential for dissociation of the toxic free 
gadolinium ion, conferring a potential 
risk for the development of NSF in the 
child or mother. Because the risk is 
unknown, it is generally recommended 
that gadolinium chelates not be used 
routinely in pregnant patients.21 Since it 
is unclear how GBCAs will affect the 
fetus, they should be used only with 
caution, when their usage is considered 
critical and the potential benefits justify 
the potential risk to the unborn fetus. If a 
GBCA is to be used in a pregnant 
patient, one of the agents believed to be 
at low risk for the development of NSF25 
should be used at the lowest possible 
dose to achieve diagnostic results. In 
pregnant patients with severely impaired 
renal function, the same precautions 
should be used as in non-pregnant 
patients. 
General Recommendation of the 
Committee on Drugs and Contrast 
Media  
At the present time, the Committee on 
Drugs and Contrast Media recommends 
the following in patients in whom 
imaging studies are requested that may 
require the use of iodinated contrast 
media or gadolinium based contrast 
media.21  
A) The radiologist should confer with the 
referring physician and document the 
following in the radiology report or the 
patient’s medical record:  
1. That information requested from 
the CT or MRI study cannot be 
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acquired without the use of IV 
contrast or by using other 
imaging methods.  
2. The information needed affects 
the care of the patient and/or 
fetus during the pregnancy.  
3. That the referring physician is of 
the opinion that it is not prudent 
to wait to obtain this information 
until after the patient is no longer 
pregnant. 
B) It is recommended that both pregnant 
patients undergoing CT or MRI with 
contrast media and their referring 
physicians should indicate that they 
understand the potential risks and 
benefits of procedures to be performed, 
alternative diagnostic options available 
(if any), and that they wish to proceed. 
Management of patients exposed to 
radiation during pregnancy 
Although avoidance of exposure to 
ionizing radiation is preferable for 
pregnant women, exposure may occur 
in some situations such as medical 
necessity, unknown pregnancy at the 
time of diagnostic or therapeutic 
intervention and workplace exposure. 
When there is an exposure, the first step 
is to estimate the cumulative radiation 
dose to the fetus. Approximate fetal 
radiation doses for common radiological 
procedures are given in Table 3.2,8,17,18 
Complex calculations are required for 
internal radiation doses because 
substances needed for fetal growth and 
development such as iodine may 
concentrate in fetal tissue and 
radioactive substances may concentrate 
in maternal tissues surrounding the 
uterus. Once the fetal radiation dose is 
estimated, the potential health effects 
can be evaluated. Discussions with 
pregnant women should include the 
immediate and short-term risks to the 
fetus, as well as the estimated long-term 
risks to the fetus such as cancer. 
Thereafter, pregnant women should be 
counseled in a nondirective manner and 
encouraged to make an informed 
decision about pregnancy 
management.26 
All pregnant women are entitled to 
counseling before exposure to radiation. 
The extent of communication about the 
effects of radiation should be related to 
the level of risk. A detailed explanation 
should be provided if the anticipated 
fetal dose or actual exposure exceeds 
10 mGy (1 rad).4 Women should be 
counseled that diagnostic radiography 
during pregnancy is safe under most 
circumstances and radiation exposure 
from a single diagnostic imaging 
procedure has not been associated with 
an increase in fetal anomalies or 
pregnancy loss.17 Exposure to a 
cumulative dose of less than 50 mGy 
that is approximately equivalent to the 
radiation dose of 500 chest 
radiographies or 100 abdominal CT 
scans has not been shown to affect 
pregnancy outcomes compared with 
control populations exposed to 
background radiation.3,4  
Conclusion 
Pregnant women are at risk of being 
exposed to radiation caused by medical 
and environmental reasons. Nonionizing 
radiation and contrast media used in 
some radiological examinations are 
considered less risky than ionizing 
radiation; however, further studies are 
required to clearly evaluate the effects 
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of nonionizing radiation and contrast 
media. Ionizing radiation has significant 
risks for the fetus including teratogenic, 
carcinogenic and mutagenic effects. 
Physicians should be especially aware 
of the risks of medical imaging 
modalities performed in pregnant 
women, ionizing radiation is more 
deleterious in the first trimester of 
pregnancy compared to other trimesters 
and its effects are associated with the 
level of exposure doses. Unlike 
carcinogenic effects which are 
independent of the dose, other effects of 
ionizing radiation have not been 
identified at any stage of gestation with 
less than 50 mGy (5 rad) exposure 
dose. Although a diagnostic radiography 
or single imaging procedure during 
pregnancy is generally not associated 
with an increase in fetal anomalies or 
pregnancy loss, physicians should be 
careful about medical imaging 
procedures. The use of imaging 
procedures such as US and MRI should 
be encouraged instead of imaging 
procedures with ionizing radiation. 
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